1,916 research outputs found
Measurement of the mass difference m(D-s(+))-m(D+) at CDF II
We present a measurement of the mass difference m(D-s(+))-m(D+), where both the D-s(+) and D+ are reconstructed in the phipi(+) decay channel. This measurement uses 11.6 pb(-1) of data collected by CDF II using the new displaced-track trigger. The mass difference is found to be m(D-s(+))-m(D+)=99.41+/-0.38(stat)+/-0.21(syst) MeV/c(2)
Measurement of the B(+) production cross section in pp(-) collisions at root s=1960 GeV RID G-1087-2011 RID E-4473-2011
We present a new measurement of the B(+) meson differential cross section d sigma/dp(T) at root s=1960 GeV. The data correspond to an integrated luminosity of 739 pb(-1) collected with the upgraded CDF detector (CDF II) at the Fermilab Tevatron collider. B(+) candidates are reconstructed through the decay B(+)-> J/psi K(+), with J/psi ->mu(+)mu(-). The integrated cross section for producing B(+) mesons with p(T)>= 6 GeV/c and vertical bar y vertical bar <= 1 is measured to be 2.78 +/- 0.24 mu b. RI Ruiz, Alberto/E-4473-2011; Robson, Aidan/G-1087-2011; De Cecco, Sandro/B-1016-2012; Prokoshin, Fedor/E-2795-2012; Azzi, Patrizia/H-5404-201
Message from the chairpersons
The 2013 IEEE Workshop on Environmental, Energy, and Structural Monitoring Systems is the fifth edition of a
meeting whose success and interest have steadily grown in the last years. The wide and increasing need for smart
monitoring solutions requires new flexible systems, design methodologies and technologies for improving quality of life,
energy efficiency and safety in houses, buildings and transportation. For this reason, the goal of the workshop is to
present novel research results and to discuss key technological issues and relevant methodological aspects related to
the development of complex systems for environmental, energy, and structural monitoring. The topics of the workshop
concern with, but they are not limited to, innovative sensors, wireless and wired sensor networks, signal/image
processing techniques as well as distributed, autonomous measurement systems and the related applications. During
this edition of the Workshop particular attention is devoted to edge-technology solutions for natural hazard monitoring,
control systems and disaster management.
This year the Workshop is sponsored by the IEEE Italy Section, technically co-sponsored by the IEEE Italy Section
Systems Council Chapter and by the IEEE Italy Section Instrumentation and Measurement Society Chapter, and
organized by the Department of Industrial Engineering of the University of Trento, Trento, Italy.
The venue in Trento, a nice town in the middle of Alps, in the premises of the new scientific and technological center
“Fabio Ferrari” offers to participants and attendees a wonderful location and a stimulating environment to present and
to discuss the most recent developments and research results in the wide area of complex monitoring systems.
In this message, our first thoughts are for the organizes and for all people who actively contributed to the success of
the Workshop, to the technical program Chairs who prepared such an interesting and up-to-date program, to the
reviewers who greatly helped in evaluating the manuscripts, to the authors who strived to present their most recent
research results, and to the Communication Office of the University of Trento that arranged the venue and managed
the related administrative aspects.
We would like to thank also all attendees for their interest in the Workshop. Some of them are newcomers, others took
part already to previous editions of the Workshop, but all of them share the same interest for research and the same
passion in solving practical problems with creative and innovative solutions. We hope that the new knowledge
presented in the technical program will provide attendees useful ideas and information to support and stimulate their
job and their future research activities. Also, we hope that the stay of participants will be both enjoyable and fruitful for
future cooperation at national and international level
Measurement of the ratios of branching fractions B (B-s(0)-> D-s(-) pi(+) pi(+) pi(-))/B(B-0 -> D- pi(+) pi(+) pi(-)) and B(B-s(0) -> D-s(-) pi(+))/B(B-0 -> D- pi(+))
Using 355 pb(-1) of data collected by the CDF II detector in p (p) over bar at collisions at root s = 1.96 TeV at the Fermilab Tevatron, we study the fully reconstructed hadronic decays B-(s)(0) -> D-(s)(-)pi(+) and B-(s)(0) -> D-(s)(-) pi(+)pi(+)pi(-). We present the first measurement of the ratio of branching fractions B(B-s(0) -> D-s(-) pi(+)pi(+)pi(-))/B(B-0 -> D-s(-) pi(+)pi(+)pi(-)) = 1.05 +/- 0.10(stat) +/- 0.22(syst). We also update our measurement of B(B-s(0) -> D-s(-)pi(+))/B(B-0 -> D-pi(+)) to 1.13 +/- 0.08(stat) +/- 0.23(syst), improving the statistical uncertainty by more than a factor of 2. We find B(B-s(0) -> D-s(-)pi(+)) = [3.8 +/- 0.3(stat) +/- 1.3(syst)] x 10(-3) and B(B-s(0) -> D-s(-) pi(+)pi(+)pi(-)) = [8.4 +/- 0.8 (stat) +/- 3.2(syst)] x 10(-3)
Erlotinib for advanced pancreatic cancer
Background Indolent non-Hodgkin's lymphoma, in particular follicular lymphoma (FL), is characterized by multiple remissions and relapses. Severalstudies have used interferon-alpha (IFN) to control this disease, both as induction and as maintenance therapy. It is not yet clear whetherIFN can be associated with a survival benefit although it may prolong progression-free survival.ObjectivesTo determine the effects of IFN in the maintenance therapy of FL.Search methodsWe searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, Issue 4, 2008), MEDLINE (1966 to 2008),DARE (1990 to 2008), SCOPUS (searched December 2008) and Current Contents (1975 to 2008). .Selection criteriaRandomised controlled trials of IFN versus no intervention or placebo, or IFN plus chemotherapy versus chemotherapy alone, in amaintenance setting in patients with non-Hodgkin's FL. Primary outcomes were overall survival and progression-free survival.Data collection and analysisThree review authors independently assessed trial quality and extracted data. We contacted study authors for additional information. Wecollected adverse events information from the trials.Main resultsWe included eight trials (1563 patients). The drug was IFN alfa-2b in six trials and alfa-2a in two. Trials were heterogeneous in termsof diagnosis of FL, using several classification systems. IFN had been compared with placebo/no intervention in five trials and otherchemotherapy in three. The effect of IFN was similar to that of placebo on overall survival (hazard ratio (HR) 0.90, 95% CI 0.61 to 1.34)whereas IFN was more effective when added to chemotherapy (HR 0.68, 95% confidence interval (CI) 0.52 to 0.90). Considering IFN versusInterferon-alpha for maintenance of follicular lymphoma (Review) all comparators, IFN was effective in prolonging progression-free survival (HR 0.66, 95% CI 0.57 to 0.77) and overall survival (fixed effectsHR 0.79, 95% CI 0.67 to 0.94, I2 = 52%). After adjustment for heterogeneity this statistically significance disappeared (random effects HR0.82, 95% CI 0.63 to 1.08). Toxicity and patients lost to follow up were significantly higher in the IFN groups.Authors' conclusionsThere is evidence that addition of IFN as maintenance therapy for FL improves progression-free survival. A net benefit for overall survival isless evident. In the included studies, IFN was associated with significant toxicities that may have a major impact on a patient's quality of lif
Measurement of the ratios of branching fractions B(B-s(0)-> D-s(-)pi(+))/B(B-0 -> D-pi(+)) and B(B+->(D)over-bar(0)pi(+))/B(B-0 -> D-pi(+))
We report an observation of the decay B-s(0)-> D-s(-)pi(+) in p (p) over bar collisions at root s = 1.96 TeV using 115 pb(-1) of data collected by the CDF II detector at the Fermilab Tevatron. We observe 83 +/- 11(stat) B-s(0)-> D-s(-)pi(+) candidates, representing a large increase in statistics over previous measurements and the first observation of this decay at a p (p) over bar collider. We present the first measurement of the relative branching fraction B(B-s(0)-> D-s(-)pi(+))/B(B-0 -> D-pi(+))=1.32 +/- 0.18(stat)+/- 0.38(syst). We also measure B(B+->(D) over bar (0)pi(+))/B(B-0 -> D-pi(+))=1.97 +/- 0.10(stat)+/- 0.21(syst), which is consistent with previous measurements
First Observation of B-s(0)->(DsK -/+)-K-+/- and Measurement of the Ratio of Branching Fractions B(B-s(0)->(DsK -/+)-K-+/-)/B(B-s(0)-> D-s(+)pi(-))
A combined mass and particle identification fit is used to make the first observation of the decay B-s(0)->(DsK -/+)-K-+/- and measure the branching fraction of B-s(0)->(DsK -/+)-K-+/- relative to B-s(0)-> D-s(+)pi(-). This analysis uses 1.2 fb(-1) integrated luminosity of pp collisions at s=1.96 TeV collected with the CDF II detector at the Fermilab Tevatron collider. We observe a B-s(0)->(DsK -/+)-K-+/- signal with a statistical significance of 8.1 sigma and measure B(B-s(0)->(DsK -/+)-K-+/-)/B(B-s(0)-> D-s(+)pi(-))=0.097 +/- 0.018(stat)+/- 0.009(syst)
Combined effects of backward treadmill training and botulinum toxin type a on spasticity and gait impairments in patients with chronic stroke - a pilot, single blind, randomized controlled trial
Non present
Artificial intelligence in cardiac radiology
Artificial intelligence (AI) is entering the clinical arena, and in the early stage, its implementation will be focused on the automatization tasks, improving diagnostic accuracy and reducing reading time. Many studies investigate the potential role of AI to support cardiac radiologist in their day-to-day tasks, assisting in segmentation, quantification, and reporting tasks. In addition, AI algorithms can be also utilized to optimize image reconstruction and image quality. Since these algorithms will play an important role in the field of cardiac radiology, it is increasingly important for radiologists to be familiar with the potential applications of AI.The main focus of this article is to provide an overview of cardiac-related AI applications for CT and MRI studies, as well as non-imaging-based applications for reporting and image optimization
Ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes as potential antimetastatic agents: synthesis, characterisation and in vitro pharmacological evaluation
- …
